z-logo
open-access-imgOpen Access
Successful Treatment of Bacteremia Due to NDM-1-Producing Morganella morganii with Aztreonam and Ceftazidime-Avibactam Combination in a Pediatric Patient with Hematologic Malignancy
Author(s) -
Claire Amaris Hobson,
Stéphane Bonacorsi,
Mony Fahd,
André Baruchel,
Aurélie Cointe,
Nora Poey,
Hervé Jacquier,
C. Doit,
Audrey Monjault,
Olivier Tenaillon,
André Birgy
Publication year - 2018
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.02463-18
Subject(s) - morganella morganii , aztreonam , ceftazidime/avibactam , bacteremia , medicine , ceftazidime , intensive care medicine , microbiology and biotechnology , antibiotics , enterobacteriaceae , biology , bacteria , pseudomonas aeruginosa , biochemistry , genetics , escherichia coli , gene

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom